Evidence map›Paper›PMID 37450837›Full record

ArticleBiomacromolecules2023

Dopamine-Conjugated Bovine Serum Albumin Nanoparticles Containing pH-Responsive Catechol-V(III) Coordination for In Vitro and In Vivo Drug Delivery.

Eda Argitekin, Esra Ersoz-Gulseven, Gulcin Cakan-Akdogan, Yasar Akdogan

Open access · hybridAbstract read
In one paragraph

Article in Biomacromolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Tumor-Targeting TACS omega · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Eda ArgitekinMaterials Science and Engineering Department, Izmir Institute of Technology, Izmir 35433, Turkey.
Esra Ersoz-GulsevenIzmir Biomedicine and Genome Center, Izmir 35340, Turkey.ORCID 0000-0003-2541-9388
Gulcin Cakan-AkdoganIzmir Biomedicine and Genome Center, Izmir 35340, Turkey.ORCID 0000-0002-6356-5979
Yasar AkdoganMaterials Science and Engineering Department, Izmir Institute of Technology, Izmir 35433, Turkey.ORCID 0000-0002-2465-8873
Izmir Institute of Technology · TRIzmir University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

V(III) instead of commonly used Fe(III) provided a rich tris-catechol-metal coordination at pH 7.4, which is important for slow drug release at physiological pH. Bovine serum albumin (BSA) functionalized with catechol-containing dopamine (D) and cross-linked using tris-catechol-V(III) coordination yielded pH-responsive compact D-BSA NPs (253 nm). However, conversion to bis- and/or mono-catechol-V(III) complexes in an acidic medium resulted in degradation of NPs and rapid release of doxorubicin (DOX). It was shown that D-BSA NPs entered cancerous MCF-7 cells (66%) more efficiently than non-cancerous HEK293T (33%) in 3 h. Also, DOX-loaded NPs reduced cell viability of MCF-7 by 75% and induced apoptosis in a majority of cells after 24 h. Biodegradability and lack of hemolytic activity were shown in vitro, whereas a lack of toxicity was shown in histological sections of zebrafish. Furthermore, 30% of circulating tumor cells in vasculature in 24 h were killed by DOX-loaded NPs shown with the zebrafish CTC xenograft model.

Indexed as

NanoparticlesSerum Albumin, BovineAnimalsCatecholsDopamineDoxorubicinDrug CarriersDrug Delivery SystemsDrug LiberationFerric CompoundsHEK293 CellsHumansHydrogen-Ion ConcentrationZebrafishcatecholCatecholsDopamineDoxorubicinDrug CarriersFerric CompoundsSerum Albumin, Bovine

Identifiers

PMID37450837
PMCPMC10428161
OpenAlexW4384282227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.